Home » FDA Partially Grants Petition on Generic Opioid Testing

FDA Partially Grants Petition on Generic Opioid Testing

April 5, 2017

Pharmaceuticals Quality

The FDA partially granted a petition filed on behalf of Purdue Pharma concerning generic versions of an extended-release opioid.

To View This Article:

Login

30Nov
CDRH’s Proposed Rule Harmonizing QSR and ISO 13485: Everything Devicemakers Must Know and Do to Prepare
07Dec
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
08Dec
Simplifying Oncology Trials: Make the Most of Remote Monitoring and Decentralization
08Dec
Extractables and Leachables: Taking a Deeper Dive
09Dec
Drug Safety Reporting Requirements: Best Practices for Monitoring, Reporting and Avoiding Regulatory Missteps
15Dec
Promoting & Marketing in the Digital and Virtual World: What Regulatory, Compliance & Marketing Professionals Need to Know

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements